Literature DB >> 16787989

Cortisol production rate in posttraumatic stress disorder.

G H Trevor Wheler1, David Brandon, Aaron Clemons, Crystal Riley, John Kendall, D Lynn Loriaux, J David Kinzie.   

Abstract

CONTEXT: Several authors have reported the unsuspected finding of low cortisol levels (urinary, salivary, and serum) in patients with posttraumatic stress disorder (PTSD).
OBJECTIVE: Our objective was to assess concentrations of cortisol and its predominant metabolites, cortisol production rate (CPR), and glucocorticoid receptor (GR) binding characteristics in PTSD compared with normal subjects.
DESIGN: Matched PTSD patients and control subjects had CPR determined by a stable isotope dilution technique after infusion of deuterated cortisol. Serum cortisol, urinary cortisol, and its metabolites were measured by gas chromatography/mass spectrometry. GR binding capacity (R(o)) and ligand binding affinity (K(d)) were measured in mononuclear leukocytes.
SETTING: All subjects were tested during a 40-h admission in an inpatient clinical research center. PATIENTS AND PARTICIPANTS: Ten patients with PTSD were matched by age and gender with 10 controls. OUTCOME MEASURES: Statistical comparison was conducted for various measures of cortisol in PTSD patients and normal subjects.
RESULTS: No statistical difference was found in mean level or circadian pattern of cortisol secretion using serum or salivary immunoassay detection methods. Although in the normal range, urinary cortisol by immunoassay showed statistically lower values over a 24-h period in PTSD patients compared with controls. This finding was not confirmed by gas chromatography/mass spectrometry determination of cortisol or its metabolites. CPR was not statistically different between these groups. GR also showed no alteration in R(o) or K(d) between the groups.
CONCLUSION: The data indicate that PTSD in the chronic and unprovoked state is not characterized by an acute biological stress response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787989     DOI: 10.1210/jc.2006-0061

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder.

Authors:  Tanja Jovanovic; Justine E Phifer; Katie Sicking; Tamara Weiss; Seth D Norrholm; Bekh Bradley; Kerry J Ressler
Journal:  Psychoneuroendocrinology       Date:  2011-05-20       Impact factor: 4.905

2.  Stressors over the life course and neuroendocrine system dysregulation in Costa Rica.

Authors:  Omer Gersten; William H Dow; William D Dow; Luis Rosero-Bixby
Journal:  J Aging Health       Date:  2010-05-28

3.  Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.

Authors:  Charles F Gillespie; Lynn M Almli; Alicia K Smith; Bekh Bradley; Kimberly Kerley; Daniel F Crain; Kristina B Mercer; Tamara Weiss; Justine Phifer; Yilang Tang; Joseph F Cubells; Elisabeth B Binder; Karen N Conneely; Kerry J Ressler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-15       Impact factor: 3.568

4.  Metabolomic analysis of male combat veterans with post traumatic stress disorder.

Authors:  Synthia H Mellon; F Saverio Bersani; Daniel Lindqvist; Rasha Hammamieh; Duncan Donohue; Kelsey Dean; Marti Jett; Rachel Yehuda; Janine Flory; Victor I Reus; Linda M Bierer; Iouri Makotkine; Duna Abu Amara; Clare Henn Haase; Michelle Coy; Francis J Doyle; Charles Marmar; Owen M Wolkowitz
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

5.  The 24-hour urinary cortisol in post-traumatic stress disorder: A meta-analysis.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Shi Wu Wen; Zhipeng Wang; Xiaoli Wu; Aizhong Liu
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

Review 6.  Single-Prolonged Stress: A Review of Two Decades of Progress in a Rodent Model of Post-traumatic Stress Disorder.

Authors:  Michael J Lisieski; Andrew L Eagle; Alana C Conti; Israel Liberzon; Shane A Perrine
Journal:  Front Psychiatry       Date:  2018-05-15       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.